Does MEPOLIZUMAB Cause Dyspnoea? 9,192 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9,192 reports of Dyspnoea have been filed in association with MEPOLIZUMAB (Nucala). This represents 21.4% of all adverse event reports for MEPOLIZUMAB.
9,192
Reports of Dyspnoea with MEPOLIZUMAB
21.4%
of all MEPOLIZUMAB reports
567
Deaths
4,811
Hospitalizations
How Dangerous Is Dyspnoea From MEPOLIZUMAB?
Of the 9,192 reports, 567 (6.2%) resulted in death, 4,811 (52.3%) required hospitalization, and 613 (6.7%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 9,192 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
Off label use (2,614)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
METHOTREXATE (9,143)
Which MEPOLIZUMAB Alternatives Have Lower Dyspnoea Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE